日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The role of kinase domain dimerization in EGFR activation.

激酶结构域二聚化在 EGFR 激活中的作用。

Petrova Zaritza O, Han Long, Tsutsui Yuko, Sheetz Joshua B, Ashtekar Kumar D, Lemmon Mark A

Distinct interactions stabilize EGFR dimers and higher-order oligomers in cell membranes

不同的相互作用可稳定细胞膜中的 EGFR 二聚体和更高级的寡聚体。

Krishna C Mudumbi ,Eric A Burns ,David J Schodt ,Zaritza O Petrova ,Anatoly Kiyatkin ,Lucy W Kim ,Emma M Mangiacapre ,Irais Ortiz-Caraveo ,Hector Rivera Ortiz ,Chun Hu ,Kumar D Ashtekar ,Keith A Lidke ,Diane S Lidke ,Mark A Lemmon

A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition

活化 EGFR 中的不稳定 Y891D 突变会削弱对激酶抑制的敏感性

Daniel S Lenchner #, Zaritza O Petrova #, Lisa Hunihan, Kumar D Ashtekar, Zenta Walther, Frederick H Wilson

Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma

循环肿瘤 DNA 揭示复发/难治性 ALK 驱动神经母细胞瘤患者对劳拉替尼产生耐药性的机制

Esther R Berko #, Gabriela M Witek #, Smita Matkar #, Zaritza O Petrova #, Megan A Wu, Courtney M Smith, Alex Daniels, Joshua Kalna, Annie Kennedy, Ivan Gostuski, Colleen Casey, Kateryna Krytska, Mark Gerelus, Dean Pavlick, Susan Ghazarian, Julie R Park, Araz Marachelian, John M Maris, Kelly C Golds

Readiness to provide pharmaceutical care to transgender patients: Perspectives from pharmacists and transgender individuals

为跨性别患者提供药学服务的准备情况:药剂师和跨性别者的观点

Melin, Kyle; Hilera-Botet, Claudia R; Vega-Vélez, Dializza; Salgado-Crespo, Valeria M; Santiago, Darlene; Hernández-Agosto, Jonathan; Muñoz-Burgos, Aryam; Cajigas, Zaritza; Martínez-Vélez, José Javier; Rodríguez-Díaz, Carlos E

Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography

消除耐药性 HIV-1 逆转录酶的共价抑制剂:从设计到蛋白质晶体学

Albert H Chan, Won-Gil Lee, Krasimir A Spasov, José A Cisneros, Shalley N Kudalkar, Zaritza O Petrova, Amanda B Buckingham, Karen S Anderson, William L Jorgensen